Johnson & Johnson said on Monday it was expecting to retain a stake of about 9.5% in its newly separated consumer health unit, Kenvue, after completing a share exchange offer.
Shares of the consumer health company rose 1.4% in premarket trading.
J&J launched the exchange offer last month under which its stockholders could opt for shares of the former consumer health unit related to the spinoff.
Source : Reuters
In recent years, the European economy has shown remarkable resilience, whilst continuing to transform. This…
A number of concerns have been raised regarding retail central bank digital currency. These range…
China's solar industry is a poster child for the country’s economic rise over the last…
European defence procurement practices must evolve to embrace innovative startups and small firms, in order…
The European Union's digital rulebook could be better enforced by delegating some of the European…
The non-fungible token market exploded in 2021, but by late 2022 prices had collapsed. This…